Carnevale Francisco Cesar, Moreira Airton Mota, Harward Sardis Honoria, Bhatia Shivank, de Assis Andre Moreira, Srougi Miguel, Cerri Giovanni Guido, Antunes Alberto Azoubel
Department of Radiology, University of Sao Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo, SP, 05403-001, Brazil.
The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, USA.
Cardiovasc Intervent Radiol. 2017 Mar;40(3):366-374. doi: 10.1007/s00270-017-1569-5. Epub 2017 Jan 10.
To compare recurrence of lower urinary tract symptoms (LUTS) recurrence at 12 months following original prostate artery embolization (oPAE) or "proximal embolization first, then embolize distal" (PErFecTED) PAE for benign prostatic hyperplasia (BPH).
105 consecutive patients older than 45 years, with prostate size greater than 30 cm, International Prostate Symptom Score (IPSS) ≥ 8, quality of life (QoL) index ≥ 3, and refractory status or intolerance of medical management were prospectively enrolled between June 2008 and August 2013. The study was IRB-approved, and all patients provided informed consent. Patients underwent oPAE or PErFecTED PAE and were followed for at least 12 months. Technical success was defined as bilateral embolization and clinical success (non-recurrence) was defined as removal of the Foley catheter in patients with urinary retention, IPSS < 8 and QoL index < 3 at 12 months of follow-up. Nonparametric statistics were used to compare the study groups due to the size of the study population and distributions of clinical data.
97 patients had 12-month data and were categorized as oPAE without recurrence (n = 46), oPAE with recurrence (n = 13), PErFecTED without recurrence (n = 36), or PErFecTED with recurrence (n = 2). Recurrence was significantly more common in oPAE patients (χ , p = 0.026). Unilateral embolization was significantly associated with recurrence among patients who underwent oPAE (χ , p = 0.032).
Both oPAE and PErFecTED PAE are safe and effective methods for treatment of LUTS, but PErFecTED PAE is associated with a significantly lower rate of symptom recurrence.
比较原发性前列腺动脉栓塞术(oPAE)或“先近端栓塞,再远端栓塞”(PErFecTED)前列腺动脉栓塞术治疗良性前列腺增生(BPH)后12个月时下尿路症状(LUTS)的复发情况。
2008年6月至2013年8月期间,前瞻性纳入了105例年龄大于45岁、前列腺体积大于30 cm、国际前列腺症状评分(IPSS)≥8、生活质量(QoL)指数≥3且对药物治疗呈难治性或不耐受的连续患者。该研究经机构审查委员会(IRB)批准,所有患者均签署了知情同意书。患者接受oPAE或PErFecTED PAE治疗,并随访至少12个月。技术成功定义为双侧栓塞,临床成功(无复发)定义为尿潴留患者在随访12个月时拔除Foley导尿管、IPSS<8且QoL指数<3。由于研究人群规模和临床数据分布情况,采用非参数统计方法对研究组进行比较。
97例患者有12个月的数据,分为无复发的oPAE组(n = 46)、有复发的oPAE组(n = 13)、无复发的PErFecTED组(n = 36)或有复发的PErFecTED组(n = 2)。oPAE患者复发明显更常见(χ²,p = 0.026)。在接受oPAE的患者中,单侧栓塞与复发显著相关(χ²,p = 0.032)。
oPAE和PErFecTED PAE都是治疗LUTS的安全有效方法,但PErFecTED PAE的症状复发率显著更低。